Ellodi Pharmaceuticals is a gastroenterology-focused specialty pharmaceutical company aiming to advance treatments for Eosinophilic Esophagitis (EoE), a rare and chronic allergic inflammatory condition. The company was established in 2020 to accelerate clinical development of EoE therapies and build on the work initiated by Adare Pharmaceuticals, particularly APT-1011, which is currently in a Phase 3 clinical trial. Despite gr...
Ellodi Pharmaceuticals is a gastroenterology-focused specialty pharmaceutical company aiming to advance treatments for Eosinophilic Esophagitis (EoE), a rare and chronic allergic inflammatory condition. The company was established in 2020 to accelerate clinical development of EoE therapies and build on the work initiated by Adare Pharmaceuticals, particularly APT-1011, which is currently in a Phase 3 clinical trial. Despite growing awareness of EoE and its underserved patient population, no FDA approved treatment exists for the disease today.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.